D.35 Abnormal Test Results.pdf

PDF 99 KB Posted

Attached to
Q201--Altus CBOC Federal contract opportunity
Solicitation number
36C25923R0045
Issued by
Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19

About this file

This document outlines a critical results reporting policy for the Oklahoma City VA Health Care System. The policy defines critical test results that require immediate notification of clinicians, including positive findings of new thrombus, cardiac tamponade from echocardiograms, severely reduced ventricular function from echos or EKGs, unstable angina or arrhythmias from stress tests, and new arrhythmias or pacemaker failures from Holter monitoring or EKGs. The policy specifies notification timeframes and procedures for inpatients, outpatients, and those requiring medical care. It designates responsibilities of technicians, nurses, fellows, attending physicians and on-call cardiologists for reporting and managing critical findings. The policy is scheduled for recertification review every three years.

The related federal contract opportunity is for services at the Altus Community Based Outpatient Clinic. The solicitation comes from the Department of Veterans Affairs Veterans Health Administration VISN 19. No further details are provided on the required services, response timeline or award information.

View the file

Other files for this federal contract opportunity

Other files attached to Q201--Altus CBOC, newest first.
File Type Posted
D.4 Validated Peripheral List - Updated.pdf PDF
36C25923R0045 0004.docx DOCX document
Altus CBOC QA - Followup Questions -Response.pdf PDF
36C25923R0045 0003.docx DOCX document
Altus CBOC QA - Combined 02282024.docx DOCX document
D.38 Centrifuge Specifications.pdf PDF
36C25923R0045v2 02282024.docx DOCX document
36C25923R0045 0002.docx DOCX document
D.39 Vaccine List.pdf PDF
36C25923R0045 0001.pdf PDF
D.36 Communication of Abnormal Imaging Results.pdf PDF
D.33 Immigration Certification.pdf PDF
D.32 DBAOK20230039 Wage Determination.pdf PDF
D.25 VHA Clinic Based Telehealth Operations.pdf PDF
D.22 eQM Measure List.pdf PDF
D.21 EO C2021.pdf PDF
D.20 Lab Supplies.pdf PDF
D.15 Consult Processes and Procedures.pdf PDF
D.13 Telephone Service for Clinical Care.pdf PDF
D.8 Pre-Treatment and Transportation of Soiled Critical Medical Equipment 2.pdf PDF
D.6 Ordering and Reporting of Test Results.pdf PDF
D.3 Laboratory Manual.pdf PDF
D.2 1345 Medication Reconciliation.pdf PDF
D.19 Document Scanning Policy.pdf PDF
D.37 Documentation Checklist.pdf PDF
D.34 Org Conflict of Interest.pdf PDF
D.23 Management of Breast Cancer Screening.pdf PDF
D.18 Ancillary Testing Policy.pdf PDF
D.14 Outpatient Clinic Practice Management.pdf PDF
D.12 Service Contract Act of 1965.pdf PDF
D.9 Reporting Adverse Drug Events.pdf PDF
36C25923R0045.pdf PDF
D.31 Past Performance Questionnaire.pdf PDF
D.30 Past Performance References.pdf PDF
D.29 SCA Wage Determination 2015-5329.pdf PDF
D.27 VHA Home Telehealth Operations.pdf PDF
D.24 Outpatient Scheduling Management.pdf PDF
D.17 Contractor Security Requirements (Handbook 6500.6).pdf PDF
D.11 Suicide Prevention.pdf PDF
D.10 Rights and Responsibilities of Patients.pdf PDF
D.7 Pre-Treatment and Transportation of Soiled Critical Medical Equipment 1_01.pdf PDF
D.1 Anticoagulation Management Program.pdf PDF
D.28 Quality Assurance Surveillance Plan - Altus.pdf PDF
D.26 VHA Clinic Based Telehealth Operations.pdf PDF
D.16 Cervical Cancer Screening.pdf PDF
D.5 Healthcare Provider Medical Records Delinquencies.pdf PDF
D.4 Validated Peripheral List.pdf PDF
Show all 47

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Abnormal Test Results: CRITICAL RESULTS reportinq policy

SOP 303-02

Oklahoma City VA Health Care System Oklahoma City, Ok 73104

Signatory Authority:

Venkata Chilakapati, MD

Responsible Owner:

Venkata Chilakapati, MD

Service Line(s):

Medicine-Cardiology

Effective Date:

January 7, 2021

Recertification Date:

January 7, 2026

(A) Policy Statement: The Heart Station technologist or nurse will notify the Cardiology fellow or the designated attending cardiologist in the lab (OR on call). MDs will call the Registered Nurse or MD in charge of the patient when a critical result is noted during or after a heart and vascular procedure.

(B) Purpose of Policy: To allow for prompt identification and patient care management necessary for treatment of life-threatening conditions.

(C) Procedure: During or following a procedure, if a life-threatening result is noted, the nurse or technologist will immediately initiate the following:

1. Inpatients: notify the cardiology fellow or designated cardiologist in the lab (OR on call). MDs will call the Registered Nurse or MD in charge of the patient when a critical result is noted during or after a heart and vascular procedure. For inpatients who have been brought to the department for testing; if the patient's condition and time permits, the patient should immediately be returned to their room or the Emergency department (if different acuity level of care is required).

2. Outpatients:. retain the patient, if possible, and notify the Cardiology Fellow or the designated attending cardiologist in the lab (OR on call). MDs will call the Registered Nurse or Ordering provider or MD in charge of the patient when a critical result is noted during or after a heart and vascular procedure. If the patient's physician's office is closed, the attending on Cardiologist should evaluate the patient and arrange a cardiology consult appointment in the office.

If the patient refuses to wait, attempts to notify the patient's physician must continue until successful.

3. If medical or nursing care is needed, it may be initiated by RN, Cardiology fellows, residents or attending physicians. If care is initiated all efforts should be made to transport the patient to a patient room or the Emergency Department as soon as possible.

4. Critical test result is defined as:

Abnormal Test Results: CRITICAL RESULTS reportinq policy

ECHO:

> A positive finding of a new thrombus/ new mass/ vegetation in the heart found during a routine echo/TEE, within 30 minutes.

> A large pericardial effusion or evidence of cardiac tamponade found during a routine echo, within 30 minutes.

> New onset, severely reduced right or left ventricular systolic function, within 1-hour.

> New onset, severely enlarged right ventricle, suspicion of Pulmonary embolus, notify within 30 minutes.

> Severe/critical, unknown aortic or mitral stenosis notify within 1 hour.

STRESS:

> New ischemia with unstable angina, within 15-30 minutes.

> Unstable arrhythmias within 15-30 minutes.

HOLTER:

New arrhythmia noted when scanning a Holter or interpreting event recorder rhythm strips, within 1-hour of scanning. Arrhythmias are defined for this purpose as:

> Narrow complex tachycardia greater than 150 beats per minute for greater than 30 seconds.

> Pauses greater than 3 seconds.

> Second Type II and third-degree heart block.

> Pacemaker failure > Wide complex tachycardia of 200 beats or greater with a duration of 4 beats or more.

> Wide complex tachycardia of 160 beats or greater with a duration of 20 beats or more.

EKG:

Immediate notification within 5-10 minutes:

> New ST segment elevation 1 m or more in two contiguous leads on 12 lead

EKG.

> New ST segment depression of 2mm or more in two contiguous leads on 12 lead

EKG.

> Heart rate less than 30 beats per minute for any reason on EKG.

> Sustained ventricular tachycardia, and /or torsade de pointe on EKG.

> Narrow complex tachycardia greater than 150 beats per minute for greater than

30 seconds.

> Pauses greater than 3 seconds.

> Second Type II and third-degree heart block.

> Pacemaker failure

Abnormal Test Results: CRITICAL RESULTS reportinci policy

5. Document critical results reporting in CPRS and also mention at the end of test report.

6. REVIEW

Chief of Cardiology will review at a minimum of every three years or when there are changes to the governing documents published by the above listed references.

7. RECERTIFICATION

This SOP is scheduled for recertification on or before the last working day of January 7, 2026. In the event of contradiction with national policy, the national policy supersedes and controls.

8. SIGNATORY AUTHORITY

VehJ(ata Chilakapati, M Chief of Cardiology Section

NOTE: The signature remains valid until rescinded by an appropriate administrative action.

DISTRIBUTION:

SOPs are available at:

https ://dvagov.sharepoi nt.com/siteslokl/Memos/Lists/Medicine/darrell%205.aspx

File details come from the government source that posted it. Updated .